FBInvestor
Stocks / Prevail Therapeutics Inc- Cvr
Institutional Ownership

Prevail Therapeutics Inc- Cvr

CUSIP 532CVR108RIGQ1 2026

Analyst forecast

Analyst recommendation trends (Buy / Hold / Sell consensus) come from a market-data feed. This activates once the forecast feed is connected and this ticker is covered.

Coming soon